A novel broad-spectrum bacteriophage cocktail against methicillin-resistant Staphylococcus aureus: Isolation, characterization, and therapeutic potential in a mastitis mouse model
PLOS ONE · 15.01.2025 · 20 (1) · e0316157
DOI: 10.1371/journal.pone.0316157 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 15.01.2025. Verfasst von Maryam Banar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Phage Therapy, Staphylococcal Infections, Bacteriophages. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Bovine mastitis is a considerable challenge within the dairy industry, causing significant financial losses and threatening public health. The increased occurrence of methicillin-resistant Staphylococcus aureus (MRSA) has provoked difficulties in managing bovine mastitis. Bacteriophage therapy presents a novel treatment strategy to combat MRSA infections, emerging as a possible substitute for antibiotics. This study evaluated the therapeutic potency of a novel bacteriophage cocktail against MRSA mastitis. Two new bacteriophages (vB_SauR_SW21 and vB_SauR_SW25) with potent lytic activity against MRSA were isolated and characterized. The one-step growth curve displayed a rapid latent period (20–35 min) and substantial burst size (418 and 316 PFU/ cell). In silico analyses have confirmed the absence of antimicrobial resistance or virulence factor-encoding genes within their genomes. According to the results, combining these phages augmented their host range and virulence. The phage cocktail significantly reduced bacterial burden in a BALB/c mastitis model, demonstrating efficacy comparable to antibiotic treatment. Moreover, its administration led to decreased concentrations of IL-1β and TNF-α compared to the negative control group. The bacteriophage cocktail (SW21-SW25) exhibits a promising profile for therapeutic applications and may represent a novel substitute to antibiotics for managing MRSA bovine mastitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Pharmaceutical Biotechnology and Biotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
- Recombinant Vaccine Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mohammad Reza Pourmand
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Banar, M., Kamyab, H., Torkashvand, N., Zahraei Salehi, T., Sepehrizadeh, Z., Shahverdi, A. R., Pourmand, M. R., & Yazdi, M. H. (2025). A novel broad-spectrum bacteriophage cocktail against methicillin-resistant Staphylococcus aureus: Isolation, characterization, and therapeutic potential in a mastitis mouse model. PLOS ONE, 20(1), e0316157. https://doi.org/10.1371/journal.pone.0316157
Vancouver
Banar M, Kamyab H, Torkashvand N, Zahraei Salehi T, Sepehrizadeh Z, Shahverdi AR, et al. A novel broad-spectrum bacteriophage cocktail against methicillin-resistant Staphylococcus aureus: Isolation, characterization, and therapeutic potential in a mastitis mouse model. PLOS ONE. 2025;20(1):e0316157. doi:10.1371/journal.pone.0316157
BibTeX
@article{Banar2025,
author = {Banar, Maryam and Kamyab, Haniyeh and Torkashvand, Narges and Zahraei Salehi, Taghi and Sepehrizadeh, Zargham and Shahverdi, Ahmad Reza and Pourmand, Mohammad Reza and Yazdi, Mohammad Hossein},
title = {A novel broad-spectrum bacteriophage cocktail against methicillin-resistant Staphylococcus aureus: Isolation, characterization, and therapeutic potential in a mastitis mouse model},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {1},
pages = {e0316157},
doi = {10.1371/journal.pone.0316157}
}
EUVIMED